Implant Combination Prolongs Survival in Glioblastoma

Description: Survival in recurrent glioblastoma multiforme was extended without major toxicity by low-activity iodine-125 seeds and carmustine wafers (Gliadel) implanted simultaneously during brain surgery, researchers here said. Median overall survival time following treatment was 69 weeks and median progression-free survival time was 47 weeks in an uncontrolled trial involving 34 patients, reported Ronald Warnick, MD, and colleagues at the University of Cincinnati in the February issue of the Journal ...